ZA952056B - Expression plasmids regulated by an osmB promoter - Google Patents

Expression plasmids regulated by an osmB promoter

Info

Publication number
ZA952056B
ZA952056B ZA952056A ZA952056A ZA952056B ZA 952056 B ZA952056 B ZA 952056B ZA 952056 A ZA952056 A ZA 952056A ZA 952056 A ZA952056 A ZA 952056A ZA 952056 B ZA952056 B ZA 952056B
Authority
ZA
South Africa
Prior art keywords
expression plasmids
osmb promoter
regulated
plasmids
osmb
Prior art date
Application number
ZA952056A
Other languages
English (en)
Inventor
Meir Fisher
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of ZA952056B publication Critical patent/ZA952056B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA952056A 1994-03-22 1995-03-13 Expression plasmids regulated by an osmB promoter ZA952056B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/216,851 US5795776A (en) 1994-03-22 1994-03-22 Expression plasmids regulated by an OSMB promoter

Publications (1)

Publication Number Publication Date
ZA952056B true ZA952056B (en) 1995-12-11

Family

ID=22808753

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA952056A ZA952056B (en) 1994-03-22 1995-03-13 Expression plasmids regulated by an osmB promoter

Country Status (9)

Country Link
US (2) US5795776A (fr)
EP (1) EP0764202B1 (fr)
JP (2) JP3878207B2 (fr)
AT (1) ATE386101T1 (fr)
AU (1) AU2126695A (fr)
DE (1) DE69535704T2 (fr)
IL (1) IL113031A (fr)
WO (1) WO1995025785A1 (fr)
ZA (1) ZA952056B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2158923B1 (fr) 1998-08-06 2013-02-27 Mountain View Pharmaceuticals, Inc. Conjugués peg-urate oxydase et utilisation associée
US20040002450A1 (en) * 2000-12-29 2004-01-01 Janette Lazarovits Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US7132510B2 (en) * 2000-12-29 2006-11-07 Bio-Technology General (Israel) Ltd. Specific human antibodies for selective cancer therapy
US20040001839A1 (en) * 2000-12-29 2004-01-01 Avigdor Levanon Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US20040001822A1 (en) * 2000-12-29 2004-01-01 Avigdor Levanon Y1-isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US20040202665A1 (en) * 2002-07-01 2004-10-14 Janette Lazarovits Compositions and methods for therapeutic treatment
US20040208877A1 (en) * 2002-07-01 2004-10-21 Avigdor Levanon Antibodies and uses thereof
US20050152906A1 (en) * 2003-06-30 2005-07-14 Avigdor Levanon Specific human antibodies
US20050266009A1 (en) * 2003-06-30 2005-12-01 Savient Pharmaceuticals, Inc. Antibodies and uses thereof
US20050069955A1 (en) * 2003-06-30 2005-03-31 Daniel Plaksin Antibodies and uses thereof
DK3321359T3 (da) * 2005-04-11 2021-03-08 Horizon Pharma Rheumatology Llc Variante former af uratoxidase og anvendelse deraf
CN102807973A (zh) * 2005-04-11 2012-12-05 萨文特医药公司 尿酸氧化酶的变体形式及其用途
RU2535038C2 (ru) 2009-06-25 2014-12-10 Криэлта Фармасьютикалз ЭлЭлСи Способы и наборы для прогнозирования риска инфузионных реакций и опосредованной антителами потери ответа при терапии пэгилированной уриказой с помощью мониторинга содержания мочевой кислоты в сыворотке крови
WO2013077573A1 (fr) * 2011-11-25 2013-05-30 서울대학교산학협력단 Élément cis-régulateur dérivé du virus de l'hépatite b et son utilisation
US11034985B2 (en) 2015-11-27 2021-06-15 Evonik Operations Gmbh Method for producing L-methionine
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
EP3538135A4 (fr) 2016-11-11 2020-07-29 Horizon Pharma Rheumatology LLC Polythérapies de molécules de prednisone et d'uricase et leurs utilisations
BR112023020035A2 (pt) 2021-04-01 2023-11-14 Evonik Operations Gmbh Método enzimático para produzir l-glufosinato e seus fosfoésteres
EP4105335A1 (fr) 2021-06-16 2022-12-21 Evonik Operations GmbH Procédé enzymatique pour la production d'esters p-alkyl du l-glufosinate
EP4493709A1 (fr) 2022-03-14 2025-01-22 Evonik Operations GmbH Procede enzymatique de production de p-esters de l-glufosinate
WO2023222226A1 (fr) 2022-05-19 2023-11-23 Evonik Operations Gmbh Procédé enzymatique pour la production de l-glufosinate
WO2023222227A1 (fr) 2022-05-19 2023-11-23 Evonik Operations Gmbh Procédé enzymatique de production de l-glufosinate
WO2023232225A1 (fr) 2022-05-31 2023-12-07 Evonik Operations Gmbh Procédé enzymatique de production diastéréosélective de p-esters de l-glufosinate
WO2024061456A1 (fr) 2022-09-21 2024-03-28 Evonik Operations Gmbh Procédé enzymatique de production de l-glufosinate et de ses phosphoesters
JP2025531377A (ja) 2022-09-21 2025-09-19 エボニック オペレーションズ ゲーエムベーハー Ｌ－グルホシネート及びそのホスホエステルを製造するための酵素法
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76959B (fr) * 1981-01-02 1984-09-04 Univ New York State Res Found
US4666836A (en) * 1981-01-02 1987-05-19 The Research Foundation Of State University Of New York Novel cloning vehicles for polypeptide expression in microbial hosts
US4624926A (en) * 1981-01-02 1986-11-25 The Research Foundation Of State University Of New York Novel cloning vehicles for polypeptide expression in microbial hosts
US4863855A (en) * 1982-05-14 1989-09-05 The Research Foundation Of State University Of New York Novel cloning vehicles for polypeptide expression in microbial hosts
GB2121054B (en) * 1982-05-25 1986-02-26 Lilly Co Eli Cloning vectors for expression of exogenous protein
US4745069A (en) * 1982-05-25 1988-05-17 Eli Lilly And Company Cloning vectors for expression of exogenous protein
JPS59203495A (ja) * 1983-04-28 1984-11-17 Kyowa Hakko Kogyo Co Ltd 外来遺伝子の新規な発現方法
US4643969A (en) * 1983-07-25 1987-02-17 The Research Foundation Of State University Of New York Novel cloning vehicles for polypeptide expression in microbial hosts
US4757013A (en) * 1983-07-25 1988-07-12 The Research Foundation Of State University Of New York Cloning vehicles for polypeptide expression in microbial hosts
DE3445517C2 (de) * 1984-12-13 1993-11-18 Ciba Geigy Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins
US4987070A (en) * 1987-03-04 1991-01-22 Suntory Limited Use of a 97 amino acid leader sequence from the E. coli B-galactosidase gene for the production of hanp and hptc as fusion proteins
US5063158A (en) * 1987-11-09 1991-11-05 Eli Lilly And Company Recombinant DNA expression vector comprising both transcriptional and translational activating sequences
US5348867A (en) * 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface

Also Published As

Publication number Publication date
JP2006068019A (ja) 2006-03-16
EP0764202A1 (fr) 1997-03-26
EP0764202A4 (fr) 1998-01-07
US5945304A (en) 1999-08-31
JPH10500565A (ja) 1998-01-20
EP0764202B1 (fr) 2008-02-13
WO1995025785A1 (fr) 1995-09-28
IL113031A0 (en) 1995-06-29
US5795776A (en) 1998-08-18
ATE386101T1 (de) 2008-03-15
DE69535704T2 (de) 2009-02-12
JP3878207B2 (ja) 2007-02-07
DE69535704D1 (de) 2008-03-27
IL113031A (en) 2006-07-05
AU2126695A (en) 1995-10-09

Similar Documents

Publication Publication Date Title
IL113031A0 (en) Expression plasmids regulated by an osmb promoter
AP8600035A0 (en) Hepatitis B surface antigen formed by recombinant DNA Techniques, vaccines, diagnostics, cell lines and methods of forming same.
EP0263311A3 (fr) Production du facteur de nécrose de tumeurs par des levures
ES2014527A6 (es) Procedimiento para la determinacion de virus sida.
HU9603155D0 (en) Papillomavirus vaccines
AU6733487A (en) Mammalian interleukin-4
PT1666591E (pt) Citoquina que induz apoptose
AU2474892A (en) Highly stable recombinant yeasts for the production of recombinant proteins
WO1989007136A3 (fr) Hepatocytes modifies et leurs utilisations
EP0244234A3 (en) Transformation of trichoderma
AU2353184A (en) A polycistronic expression vector for vertebrate cells
IE872455L (en) Improved recombinant expression
AU5233686A (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
HU9202458D0 (en) Expressing systems
GR851866B (fr)
AU6661490A (en) Novel polypeptides, the DNA sequences allowing their expression, method of preparation, and utilization
EP0174444A3 (en) Hepatitis surface antigen particle vaccine
IL90334A0 (en) Genetic transformation of b.thuringiensis,vectors used therefor,host cells transformed by the vectors and use of said cells as insecticides
AU2085195A (en) Gene coding for igg-fc-binding protein
CA2014948A1 (fr) Genes codant pour une proteine ayant une activite macif humaine, vecteurs d'expression contenant ces genes, cellules transformees et proteines ayant une activite macif humaine
IL97000A0 (en) Recombinant dna expression vectors and dna compounds that encode isopenicillin n epimerase activity
AU7963487A (en) Recombinant ligninase
EP0422217A4 (en) Human recombinant placental ribonuclease inhibitor and method of production
EP0591548A4 (en) Anti-hbs antibody gene and expression plasmid thereof
EP0254315A3 (en) Method for producing peptides